2013.09.30 Weekly Broadcast Email
The following updates were made to the CCCWF CCOP Research Base website for the week of September 30, 2013.
Attention sites with patients on the follow studies:
99211: Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients Receiving Outpatient Treatment: A Pilot Study
99311: Randomized Placebo-Controlled Phase 2 Pilot Study of Memantine (Namenda) for Smoking Cessation among Cancer Survivors
Please check your NicAlert test strips as some will expire this month. Only use the NicAlert strips dated 11/2014. If you have any questions, please contact Sarah Hahne. (firstname.lastname@example.org)
During the month of September, 21 patients were accrued to CCCWF CCOP Research Base trials. Congratulations to the Wichita CCOP for accruing the most patients. See the Research Base website spotlight section for further information.
There were 5 adverse events received during the month of September.
99211 AE 14-17, and 97211 AE 4
They have been attached to this email and summarized on the AE page of the website.
Sarah C. Hahne, CCRP
Protocol Information Office
CCCWFU CCOP Research Base
Wake Forest University School of Medicine
Medical Center Boulevard
Winston Salem, NC 27157
Office Hours: Monday and Wednesday 8-5
CONFIDENTIAL AND PRIVILEGED: The information contained in this electronic message may be privileged and confidential information intended for the sole use of the addressee and any personnel receiving a copy. If the reader of this electronic message is not the intended recipient, or the employee or agent responsible for delivering it to the intended recipient, you are hereby notified that any dissemination, distribution or copying of this communication is strictly prohibited. If you have received this electronic message in error, please notify me immediately by responding to this message.
WITHHOLD FROM PUBLIC DISCLOSURE UNDER N.C.G.S. 104E-9(a)(4)